This is a finding from a lab test, often from a Pap smear, that looks at cells from the cervix (the lower part of the uterus). It means some of the cells on the surface of the cervix are looking abnormal.
Every report comes from a Lived member, sent anonymously.
Have you had LEEP for Squamous Intraepithelial Lesions of the Cervix?
A squamous intraepithelial lesion (SIL) is an area of abnormal cells on the surface of the cervix, the narrow lower end of the uterus that opens into the vagina. It is usually found on a Pap test, which looks at a small sample of cervical cells under a microscope. The name describes where the change is: in the thin, flat (squamous) cells that line the cervix, and only within that surface layer (intraepithelial). SIL is not cancer, and an abnormal Pap result does not mean someone has cancer. It matters because some of these changes, left alone for years, can develop into cervical cancer, while many others go away on their own. Results are reported in two grades. A low-grade lesion (LSIL) means mild changes that are usually caused by a human papillomavirus (HPV) infection and often clear without treatment. A high-grade lesion (HSIL) means moderately or severely abnormal cells that could become cancer in the future if not treated. Most people have no symptoms at all, which is why these changes are found through screening rather than because something feels wrong.
Nearly all of these changes are caused by HPV, a very common virus spread through intimate skin-to-skin and sexual contact. Most sexually active people get HPV at some point, and the immune system usually clears it within a year or two. The problem arises when one of the high-risk HPV types, such as HPV 16 or 18, persists for years. That long-lasting infection is what gradually changes cervical cells into a precancerous lesion. Some factors make it more likely that an infection persists or progresses. These include a weakened immune system (for example, from HIV, the human immunodeficiency virus, or from medicines taken after an organ transplant or for autoimmune disease) and smoking, including exposure to secondhand smoke. Starting sexual activity young and having more partners raise the chance of acquiring high-risk HPV in the first place. None of these factors means a person did something wrong, and many people with an SIL have none of them. The HPV vaccine (Gardasil 9) prevents infection with the HPV types that cause most cervical precancers and cancers. It works best when given before any exposure, typically at ages 11 to 12, and is approved through age 45. It does not treat an infection or lesion that is already present, so vaccinated people still need screening.
An SIL is a screening result, not a final diagnosis. A Pap test (also called cervical cytology) shows that cells look abnormal, and an HPV test on the same sample shows whether high-risk HPV is present. Doctors in the United States now decide the next step based on a person's estimated risk of developing serious precancer, combining the current result with past screening results, past treatment and age, rather than on the Pap label alone. For a high-grade result (HSIL), or a borderline result called ASC-H (atypical squamous cells, where a high-grade lesion cannot be ruled out), the usual next step is colposcopy. During colposcopy, a clinician uses a lighted magnifying instrument to look closely at the cervix after applying a vinegar solution that makes abnormal areas stand out, and takes small biopsies of anything suspicious. The biopsies can cause brief cramping and a little bleeding afterward. For a low-grade result (LSIL), colposcopy is often recommended too, though some people at lower risk, and many people under 25, are followed with repeat testing instead. A biopsy is graded as cervical intraepithelial neoplasia (CIN) on a scale of 1 to 3. CIN 1 is mild and roughly matches LSIL. CIN 2 is moderate and CIN 3 is severe; both fall under HSIL. CIN 3 is not cancer, but it is considered the direct forerunner of cervical cancer, and the biopsy grade, more than the Pap result, guides treatment.
Many lesions need no treatment. CIN 1 usually clears on its own, so the plan is typically repeat HPV or Pap testing to make sure it does not persist or progress. When treatment is needed, the aim is to remove or destroy the abnormal area before it can become cancer. The most common approach in the United States is a loop electrosurgical excision procedure (LEEP), in which a thin, electrically heated wire loop removes a shallow, cone-shaped piece of the cervix. It is usually done in a doctor's office under local anesthetic and takes a few minutes. Cold knife conization removes a similar piece with a scalpel and is done in a hospital under anesthesia. Excision is generally preferred because the removed tissue can be examined to confirm the grade and check that the edges are clear. Ablation, which destroys the tissue by freezing (cryotherapy) or with a laser, is an alternative when the whole lesion is visible and certain other conditions are met, but it leaves no sample to examine. Hysterectomy is not used as a first treatment for these lesions. The decision depends heavily on the grade. CIN 3 should be treated in anyone who is not pregnant. CIN 2 is usually treated, but about half of CIN 2 lesions regress on their own, so close observation with colposcopy and testing every 6 months is an option, and is preferred for people under 25. The main trade-off is pregnancy: excision slightly raises the risk of premature birth and low birth weight in later pregnancies. People who hope to become pregnant can weigh that against the risk of the lesion progressing. During pregnancy, high-grade lesions are monitored and treatment is generally postponed until after delivery unless cancer is suspected.
For most people, an SIL is a manageable finding rather than a serious illness. Low-grade changes often disappear within a year or two as the body clears HPV. High-grade changes that are found and treated are usually cured, and the treatment itself is typically a short outpatient procedure. After LEEP or a cone procedure, mild cramping and a watery, pinkish or brownish discharge for a few weeks are common while the cervix heals. Clinicians usually advise avoiding sex, tampons and douching for about four to six weeks, or until they say it is safe. Follow-up is the part that lasts. After treatment for a high-grade lesion, an HPV-based test is usually repeated at 6 months and then yearly until three tests in a row are negative. Because the risk of cervical cancer stays somewhat higher than average for decades, testing then continues every 3 years for at least 25 years, even past age 65. Lesions can come back, and a positive follow-up test leads to another colposcopy. Smoking raises the risk of more severe changes, so quitting is one of the few things a person can do that helps.
Book a follow-up visit if you have had an abnormal Pap or HPV result and have not heard back or are unsure of the plan, or if you are due for monitoring after a past abnormal result. Bleeding after sex, between periods or after menopause, or unusual discharge, should also be checked even if a recent screening test was normal. After LEEP or another cervical procedure, call your gynecologist promptly for heavy bleeding (more than a normal period), bleeding with clots or severe abdominal pain.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Squamous Intraepithelial Lesions of the Cervix is like, what's helped you, or ask the community a question.